Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$23.84 - $32.03 $138,272 - $185,774
-5,800 Reduced 34.94%
10,800 $328,000
Q2 2021

Aug 16, 2021

SELL
$29.06 - $38.83 $499,832 - $667,876
-17,200 Reduced 50.89%
16,600 $482,000
Q1 2021

May 18, 2021

BUY
$39.04 - $64.6 $101,504 - $167,959
2,600 Added 8.33%
33,800 $1.46 Million
Q4 2020

Feb 17, 2021

SELL
$42.46 - $56.58 $1.01 Million - $1.35 Million
-23,900 Reduced 43.38%
31,200 $1.44 Million
Q3 2020

Nov 17, 2020

BUY
$37.44 - $64.63 $1.78 Million - $3.07 Million
47,500 Added 625.0%
55,100 $2.39 Million
Q2 2020

Aug 17, 2020

BUY
$17.62 - $58.71 $133,912 - $446,196
7,600 New
7,600 $403,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $17.4M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.